Rizatriptan benzoate and Hyperhidrosis - a phase IV clinical study of FDA data
Summary:
Hyperhidrosis is reported as a side effect among people who take Rizatriptan benzoate (rizatriptan benzoate), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Ibuprofen, and have Hypoaesthesia.
The phase IV clinical study analyzes which people have Hyperhidrosis when taking Rizatriptan benzoate. It is created by eHealthMe based on reports of 1,704 people who have side effects when taking Rizatriptan benzoate from the FDA, and is updated regularly.
What is Rizatriptan benzoate?
Rizatriptan benzoate has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,886 Rizatriptan benzoate users. Check the latest studies of Rizatriptan benzoate.
What is Hyperhidrosis?
Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,546 drugs and 3,546 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1,704 people reported to have side effects when taking Rizatriptan benzoate.
Among them, 65 people (3.81%) have Hyperhidrosis.

Among these 65 people:
How long have people been on Rizatriptan benzoate when they have Hyperhidrosis? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 80 %
- 1 - 2 years: 20 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hyperhidrosis when taking Rizatriptan benzoate? *
- female: 79.07 %
- male: 20.93 %
What is the age of people who have Hyperhidrosis when taking Rizatriptan benzoate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 2.38 %
- 40-49: 52.38 %
- 50-59: 16.67 %
- 60+: 28.57 %
What are other drugs people take besides Rizatriptan benzoate? *
- Topiramate: 21 people, 32.31%
- Ibuprofen: 21 people, 32.31%
- Singulair: 20 people, 30.77%
- Gabapentin: 19 people, 29.23%
- Venlafaxine Hydrochloride: 19 people, 29.23%
- Celecoxib: 17 people, 26.15%
- Ventolin: 17 people, 26.15%
- Demerol: 16 people, 24.62%
- Acetaminophen: 16 people, 24.62%
- Dihydroergotamine Mesylate: 16 people, 24.62%
What are other side effects people have besides Hyperhidrosis? *
- Nausea (feeling of having an urge to vomit): 56 people, 86.15%
- Fatigue (feeling of tiredness): 33 people, 50.77%
- Fever: 31 people, 47.69%
- Headache (pain in head): 30 people, 46.15%
- Nausea And Vomiting: 30 people, 46.15%
- Pain: 28 people, 43.08%
- Diarrhea: 26 people, 40.00%
- Chest Pain: 25 people, 38.46%
- Mobility Decreased (ability to move is reduced): 25 people, 38.46%
- Weakness: 24 people, 36.92%
What are the existing conditions these people have? *
- Asthma: 17 people, 26.15%
- Hypoaesthesia (reduced sense of touch or sensation): 17 people, 26.15%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 20.00%
- Lung Disorder (lung disease): 13 people, 20.00%
- Sinusitis (inflammation of sinus): 11 people, 16.92%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 11 people, 16.92%
- Dizziness: 8 people, 12.31%
- Ovarian Cancer (cancer of ovary): 5 people, 7.69%
- Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 6.15%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 4.62%
* Approximation only. Some reports may have incomplete information.
Do you take Rizatriptan benzoate and have Hyperhidrosis?
- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rizatriptan benzoate:
- Rizatriptan benzoate (1,886 reports)
Hyperhidrosis treatments and more:
- Hyperhidrosis (147,206 reports)
How severe was Hyperhidrosis and when was it recovered:
Expand to all the drugs that have ingredients of rizatriptan benzoate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rizatriptan benzoate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperhidrosis:
- Hyperhidrosis (2,546 drugs)
Browse all the conditions that are associated with Hyperhidrosis:
- Hyperhidrosis (3,546 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rizatriptan benzoate (the active ingredients of Rizatriptan benzoate) and Rizatriptan benzoate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Xeljanz cause Bone Disorder? - 3 seconds ago
- Hydrochlorothiazide and Fractured Sacrum for Women aged 60+ - 4 seconds ago
- Tacrolimus and Bone Density Loss for Women aged 30-39 - 7 seconds ago
- Tacrolimus and Bone Density Decreased for Women aged 30-39 - 8 seconds ago
- Drug interactions of Fluconazole and Stavudine - 10 seconds ago
- Drug interactions of Bactrim and Doxazosin Mesylate - 15 seconds ago
- Biaxin and Ms Contin drug interactions for men aged 60+ - 20 seconds ago
- Mycotic Allergy and drugs of ingredients of amoxicillin - 23 seconds ago
- Could Paclitaxel cause Walking Disability? - 25 seconds ago
- Desferal and Exhaustion, Fatigue, Lethargy, Tiredness, Weariness for Men aged 60+ - 25 seconds ago